GEPIA revealed that three of the 21 candidate genes (i.e., SAFB, YWHAZ, and RPN1) were significantly associated with the OS and DFS of patients with PAAD (Figures 3C,D). This evidence concerns the gene SAFB and pancreatic adenocarcinoma.